Atossa Genetics Inc (ATOS)

NASDAQ
1.930
-0.170(-8.10%)
After Hours
1.930
0.000(0.00%)
- Real-time Data
  • Volume:
    5,756,216
  • Bid/Ask:
    1.920/2.010
  • Day's Range:
    1.900 - 2.095

ATOS Comments

What is your sentiment on Atossa Genetics Inc?
or
Market is currently closed. Voting is open during market hours.

All Comments

(327)
  • No volume
    2
    • guys, don't be fooled, ATOS must close the gap up to $5.34 at least
      0
      • ,🚀🚀🚀🚀🚀🚀
        0
        • ,🚀🚀🚀🚀🚀🚀
          0
          • ,🚀🚀🚀🚀🚀🚀
            0
            • Now shorties time to think about that Short Float of 18.70% (23,674,398 shares more or less) sayonara baby 💪🇺🇸💪
              0
              • 🥳🥳🥳
                0
                • On September 7, 2021, Atossa Therapeutics, Inc. (the "Company”) convened a Special Meeting of Stockholders (the "Special Meeting”) for the purpose of voting on a proposal to increase authorized shares of common stock by 100 million. As of that date, the proposal did not have sufficient yes votes to pass so the Special Meeting was adjourned until October 7, 2021 to allow additional time for voting. As of October 6, 2021, approximately 58,445,262 votes were cast in favor of the proposal which is approximately 46.2% of the outstanding shares of common stock on the record date. A majority of the issued and outstanding shares of common stock on the record date must vote in favor of the proposal for it to pass. Because the proposal has not garnered sufficient votes to pass, the Company is withdrawing the proposal and is cancelling the Special Meeting.
                  0
                  • Fasten seat belts 💥🚀 🤑🥳🥳🥳
                    0
                • SEATTLE, Sept. 30, 2021 (GLOBE NEWSWIRE) -- Atossa Therapeutics, Inc. (Nasdaq: ATOS), a clinical stage biopharmaceutical company seeking to discover and develop innovative medicines in areas of significant unmet medical need in oncology and infectious diseases with a current focus on breast cancer and COVID-19, today announces it has begun to enroll participants in its clinical study of AT-H201 in Australia. The nebulized formulation, AT-H201, is being developed as an inhalation therapy for moderately to severely-ill hospitalized COVID-19 patients and for "long-haul" patients with post-infection pulmonary disease.
                  0
                  • that Dr. Quay thinks he is cute and all the rest are inmenselly i~diot~s and our hole in the back sized the Grand Canyon, very nice of him
                    1
                    • There're not enough votes nor will there be, price should recover $5,3 as soon as possible to close the gap, the fair behavior. If executives intention is their own enrichment at any costs, let them BUY the shares spilled at the open market from US. If they force the siege for their illicit profit, they'll be sued in an organized and massive way
                      0
                      • Atossa Therapeutics Receives Approval from the Swedish Ethics Review Authority to Initiate a Phase 2 Clinical Study of Oral Endoxifen to Reduce Mammographic Breast Density in Sweden
                        0
                        • bahunwhere did you see that?
                          0
                          • they want to rip us off by adding 100 million more common shares in september almost double diluition from what it is already
                            1
                            • Walk run fly
                              1
                              • unbelivable 24% down what an attack from over 3x on my money on this stock to -ve in a month. this sucksss didnt take out my profit thinking this will hit $60 n make me a fortune 🤦🤦🤦
                                1
                                • I pulled out 2 early
                                  0
                              • ma(200)  2.75  ?  :-)
                                0
                                • Shakedown to $2.20 about to be concluded next week. Thank you for your money.
                                  3
                                  • Manipulation at its best. I am even wondering is the company trying to colluding with shorties so they can subscribe the new shares cheap to cover their short position. Lets vote this dem thing down
                                    1
                                    • Will the company consider to pay dividend so the shorts r forced to cover? Even just half a sen. Price is overly depressed by the shorts activity
                                      0
                                      • 2nd Highest Traded Unusual Options Activity
                                        0
                                        • YES!!!
                                          0
                                          • Are you ready for good news?
                                            0
                                            • Whats thr good news
                                              0
                                          • Here We go.......
                                            0
                                            • yes, go to the ********:S
                                              0
                                          • Hibernation
                                            0
                                            Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All derived (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
                                            Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.